Renaissance Technologies - ONCOMED PHARMACEUTICALS INC ownership

ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 83 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$1,882,000
+106.6%
1,809,489
+48.5%
0.00%
+100.0%
Q4 2018$911,000
-47.4%
1,218,607
+49.1%
0.00%
-50.0%
Q3 2018$1,733,000
-56.3%
817,400
-43.8%
0.00%0.0%
Q2 2018$3,970,000
+78.8%
1,455,500
+108.5%
0.00%0.0%
Q1 2018$2,220,000
+2.3%
698,100
+31.9%
0.00%0.0%
Q4 2017$2,170,000
+16.7%
529,300
+28.6%
0.00%0.0%
Q3 2017$1,860,000
+51.1%
411,600
+11.4%
0.00%0.0%
Q2 2017$1,231,000
-74.9%
369,596
-30.7%
0.00%
-71.4%
Q1 2017$4,914,000
+35.8%
533,600
+13.7%
0.01%
+16.7%
Q4 2016$3,618,000
+25.8%
469,300
+86.5%
0.01%
+20.0%
Q3 2016$2,876,000
+156.1%
251,600
+271.6%
0.01%
+66.7%
Q3 2015$1,123,000
+100.2%
67,700
+171.4%
0.00%
+200.0%
Q2 2015$561,000
+24.7%
24,942
+20.6%
0.00%0.0%
Q4 2014$450,000
-40.7%
20,675
-48.5%
0.00%
-50.0%
Q3 2014$759,000
-45.0%
40,110
-32.2%
0.00%
-33.3%
Q2 2014$1,379,00059,2000.00%
Other shareholders
ONCOMED PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 1,839,730$41,468,0007.46%
BVF INC/IL 991,433$22,347,0003.81%
Iguana Healthcare Management, LLC 400,000$9,016,0002.97%
APEX CAPITAL, LLC 382,000$8,610,0000.92%
Birchview Capital, LP 58,689$1,323,0000.76%
BRAVE ASSET MANAGEMENT INC 46,550$1,049,0000.71%
HAMILTON LANE ADVISORS LLC 44,376$1,000,0000.44%
NJ State Employees Deferred Compensation Plan 70,000$1,578,0000.32%
Eventide Asset Management 190,000$4,283,0000.21%
DISCIPLINED GROWTH INVESTORS INC /MN 308,600$6,956,0000.18%
View complete list of ONCOMED PHARMACEUTICALS INC shareholders